参考文献/References:
[1] 胡付品, 郭燕, 朱德妹, 等.2019 年CHINET 三级医院细菌耐药监测[J].中国感染与化疗杂志, 2020,20(3): 233-243.HU Fupin, GUO Yan, ZHU Demei, et al. CHINETsurveillance of bacterial resistance across tertiaryhospitals in 2019 [J]. Chinese Journal of Infection andChemotherapy, 2020, 20(3): 233-243.
[2] ZHANG Yawei, WANG Qi, YIN Yuyao, et al. Epidemiologyof carbapenem-resistant Enterobacteriaceaeinfections: report from the China CRE network[J].Antimicrobial Agents and Chemotherapy, 2018, 62(2):e01882-17.
[3] 孙艳. 耐碳青霉烯类肠杆菌科细菌耐药机制及实验室检测研究进展[J]. 国际检验医学杂志, 2020,41(16):2011-2016.SUN Yan. Research progress on the mechanism ofcarbapenems Enterobacteriaceae drug resistance andits laboratory testing [J]. International Journal ofLaboratory Medicine, 2020, 41(16): 2011-2016.
[4] 刘宇豪, 陈晨, 次仁曲珍, 等.耐碳青霉烯类肠杆菌科细菌耐药基因分析[J].现代检验医学杂志, 2018,33(2):55-57.LIU Yuhao, CHEN Chen, CIREN Quzhen, et al. Drugsensitivity and resistance gene of carbapenem resistantEnterobacteriaceae [J]. Journal of Modern LaboratoryMedicine, 2018, 33(2): 55-57.
[5] HAM D C, MAHON G, BHAURLA S K, et al. Gramnegativebacteria harboring multiple carbapenemasegenes, United States, 2012-2019[J]. EmergingInfectious Diseases, 2021, 27(9): 2475-2479.
[6] HAUCK C, COBER E, RICHTER S S, et al.Spectrum of excess mortality due to carbapenemresistantKlebsiella pneumoniae infections[J]. ClinicalMicrobiology and Infection, 2016, 22(6): 513-519.
[7] KOPOTSA K , O S E I S J , M B ELLE N M .Plasmid evolution in carbapenemase-producingEnterobacteriaceae: a review[J]. Annals of the NewYork Academy of Sciences, 2019, 1457(1): 61-91.
[8] ABE R, AKEDA Y, SUGAWARA Y, et al. Enhancedcarbapenem resistance through multimerization ofplasmids carrying carbapenemase genes[J]. mBio,2021, 12(3): e0018621.
[9] TAMMA P D, GOODMAN K E, HARRIS A D,et al. Comparing the outcomes of patients withcarbapenemase-producing and non-carbapenemaseproducingcarbapenem-resistant enterobacteriaceaebacteremia[J]. Clinical Infectious Diseases, 2017,64(3): 257-264.
[10] WILSON G M, SUDA K J, FITZPATRICK M A, et al.Risk factors associated with carbapenemase-producingcarbapenem-resistant Enterobacteriaceae positivecultures in a cohort of U S veterans[J]. Clin Infect Dis,2021 , 73(8):1370-1378.
[11] 朱明辉, 马红映, 王卫华, 等.耐碳青霉烯类肺炎克雷伯菌耐药性及碳青霉烯类失活法检测分析[J]. 中华医院感染学杂志,2019,29(3):330-334, 345.ZHU Minghui, MA Hongying, WANG Weihua, et al.Drug resistance and carbapenem inactivation methodtest analysis of carbapenem-resistant Klebsiellapneumoniae [J]. Chinese Journal of Nosocomiology,2019, 29(3):330-334, 345.
[12] 张青, 陈喆, 李克诚, 等. 改良Hodge 与Carba NP和mCIM 试验快速检测产碳青霉烯酶肺炎克雷伯菌的方法学比较[J]. 中华医院感染学杂志, 2019,29(10):1441-1446.ZHANG Qing, CHEN Zhe, LI Kecheng, et al. Acomparative study of modified Hodge test, Carba NP testand mCIM test for rapid detection of carbapenemaseproducingKlebsiella pneumoniae [J]. Chinese Journalof Nosocomiology, 2019, 29(10 ): 1441-1446.
[13] HOWARD J C, CREIGHTON J, IKRAM R, et al.Comparison of the performance of three variationsof the carbapenem inactivation method (CIM,modified CIM [mCIM] and in-house method (iCIM))for the detection of carbapenemase-producingEnterobacterales and non-fermenters[J]. J GlobAntimicrob Resist, 2020, 21:78-82.
[14] 王永红, 刘航, 邹家齐, 等.mCIM 与eCIM 检测肠杆菌科细菌碳青霉烯酶的临床评价[J].第三军医大学学报, 2020, 42(5):466-472.WANG Yonghong, LIU Hang, ZOU Jiaqi, et al.Evaluation on clinical application of mCIM and eCIMin detection of carbapenemase from EnterobacteriaceaeBacteremia [J]. Journal of Third Military MedicalUniversity, 2020, 42(5): 466-472.
[15] 杨巧玲, 王梦鹤, 林玉玲, 等.五种方法检测产碳青霉烯酶肠杆菌科细菌的卫生经济学评价[J].中国循证医学杂志, 2020, 20(2):227-233.YANG Qiaoling, WANG Menghe, LIN Yuling, etal. Health economics assessment of five methodsfor detect ion of carbapenemase-producingEnterobacteriaceae [J]. Chinese Journal of Evidence-Based Medicine, 2020, 20(2): 227-233.
[16] HAN Ren r u , S H I Q i n g y u , WU Shi, e t a l .Dissemination of carbapenemases (KPC, NDM,OXA-48, IMP, and VIM) among carbapenemresistantEnterobacteriaceae isolated from adultand children patients in China[J]. Front Cell InfectMicrobiol, 2020 , 10:314.
[17] TRACZEWSKI M M, CARRETTO E, CANTON R,et al. Multicenter evaluation of the Xpert Carba-Rassay for detection of carbapenemase genes in Gram-Negative isolates[J]. Journal of Clinical Microbiology,2018, 56(8): e00272-18.
[18] JIN Xi, ZHANG Haomin, WU Shi, et al. Multicenterevaluation of Xpert Carba-R assay for detection andidentification of the carbapenemase genes in rectalswabs and clinical isolates[J]. The Journal of MolecularDiagnostics, 2021, 23(1): 111-119.
[19] CAI Zhen, TAO Jia, JIA Tianye, et al. Multicenterevaluation of the Xpert Carba-R assay for detectionand identification of carbapenemase genes in sputumspecimens[J]. Journal of Clinical Microbiology, 2020,58(9):e00644-20.
[20] SMITH M, DIEDEREN B, SCHARRINGA J, et al.Rapid and accurate detection of carbapenemase genesin Enterobacteriaceae with the Cepheid Xpert Carba-Rassay[J]. Journal of Medical Microbiology, 2016, 65(9):951-953.
[21] 宋林键, 叶丽艳, 赵强, 等.利用GeneXpert 法检测耐碳青霉烯类肠杆菌科细菌耐药基因及耐药性分析[J].国际检验医学杂志, 2019, 40(24): 2999-3002.SONG Linjian, YE Liyan, ZHAO Qiang, et al.Detection of Carbapenem-resistant genes inEnterobacteriaceae using the Gene Xpert moleculardiagnostic system and the resistance analysis [J].International Journal of Laboratory Medicine, 2019,40(24): 2999-3002.